Pricing

Log inSign up

Enterin

0 followers
‌

Enterin is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

11-50

Links

Org chart

Michael Zasloff
Co-Founder, Chief Scientific Officer & Board Member
William Kinney
Co-Founder & SVP of R&D
Richard S. Larson
Chief Medical Officer
Kimberly Man
Vice President Operations
D. Phillip Cox
VP Commercial Manufacturing
CG
Christina Gallagher
Clinical Trials Logistics Manager
Hilde Williams
Senior Regulatory Advisor, Regulatory Strategy & Operations
Joseph Costa
Financial Controller

Board & advisors

Jay Brammer
Chairman
Mark Finn
Board Member
Richard D. Propper
Board Member
Roger Mills
Board Member
Don Munoz
Board Member
Chris Dobson
Scientific Advisor
Michael Camilleri
Scientific Advisor
Linda Greensmith
Scientific Advisor
Wolfgang Kunze
Scientific Advisor
Alexander Fleming
Scientific Advisor
Robert A. Hauser
Scientific Advisory Board Member
Patrik Brundin
Scientific Advisory Board Member
Alan Moses
Scientific Advisory Board Member
Michael Zemel
Scientific Advisory Board Member
K Ray Chaudhuri
Advisor
Tom Laughren
Advisor
Anthony Schapira
Advisor
Rajeev Kumar
Advisor
Elizabeth Cho-Fertikh
Advisor
Thyagarajan Subramanian
Advisor
Barry Miller
Board Member

Similar companies

Tango Therapeutics

3 followers

Cellares

5 followers

Gilead Sciences

175 followers

Regeneron

144 followers

Illumina

82 followers

Agilent Technologies

90 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

50 followers

GRAIL

32 followers

Cytiva

20 followers

PerkinElmer

13 followers

Explore companies